September 30, 2005
September 30, 2005 -- The Food and Drug Administration (FDA) issued proposed regulations this week in regard to new animal drugs for the purposes of Minor Uses or Minor Species (MUMS) legislation. Comments are being requested on the document, as well as on the information collection provisions.
The MUMS Animal Health Act of 2004 amended the Federal Food, Drug and Cosmetic Act to establish new regulatory procedures that provide incentives intended to make more drugs legally available to veterinarians and animal owners for the treatment of minor animal species and uncommon diseases in major animal species. These proposed regulations recommend procedures for designating a new animal drug as a MUMS drug and establishes the eligibility for the incentives provided by the MUMS act.
Paul Frischknecht, president of the American Sheep Industry Association (ASI) commented, ?ASI and industry leaders worked very hard for the passage of the MUMS legislation and are encouraged that the rule-making procedures are now officially published.?
To review the Federal Register, go to:
http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket.access.gpo.gov/2005/05-19196.htm. Comments on the information collection provisions must be submitted by Oct. 27; comments on the document must be received by Dec. 12, 2005.
Staff contact: Paul Rodgers, 303-771-3500